Pfizer Inc. Chief Executive Officer Ian Read faced increasingly hostile questioning from U.K. lawmakers today over his takeover bid for AstraZeneca Plc.
Pfizer Inc. Chief Executive Officer Ian Read refused to be pinned down on his commitment to preserve jobs in the U.K. as skeptical lawmakers grilled him about the company’s unsolicited offer for AstraZeneca Plc.
Even in a high-stakes deal worth almost $120 billion, one that would create the world’s biggest drugmaker, the personal details matter.
"We continue to look at all types of business development, regardless of size, that we believe would add value to shareholders."
- Ian Read on Jul 29, 2014